Correction: Reduction in bone relapse and improved survival with oral clodronate for adjuvant treatment of operable breast cancer [ISRCTN83688026]

doi:10.1186/bcr1413

Top
Correction
References

Breast Cancer Research

Volume 8
Issue 3

Viewing options:

Full text
PDF (25KB)

Associated material:

Readers' comments

Related literature:

Articles citing this article
on Google Scholar
on ISI Web of Science
Other articles by authors
on Google Scholar

Powles T
Paterson A
McCloskey E
Schein P
Scheffler B
Tidy A
Ashley S
Smith I
Ottestad L
Kanis J

on PubMed

Powles T
Paterson A
McCloskey E
Schein P
Scheffler B
Tidy A
Ashley S
Smith I
Ottestad L
Kanis J
Related articles/pages
on Google

on Google Scholar

Tools:

Post to:

Correction

Correction: Reduction in bone relapse and improved survival with oral clodronate for adjuvant treatment of operable breast cancer [ISRCTN83688026]

Trevor Powles¹ , Alexander Paterson², Eugene McCloskey³, Phil Schein⁴, Bobbi Scheffler⁵, Alwynne Tidy⁶, Sue Ashley⁶, Ian Smith⁶, Lars Ottestad⁷ and John Kanis³

¹Parkside Oncology, London, UK

²Tom Baker Cancer Centre, Calgary, Alberta, Canada

³WHO Collaborating Centre for Metabolic Bone Diseases, University of Sheffield Medical School, Sheffield, UK

⁴Department of Clinical Pharmacology, University of Oxford, Oxford, UK

⁵Scheffler Group, Villanova, Pennsylvania, USA

⁶Royal Marsden Hospital, London, UK

⁷Radium Institute, Oslo, Norway

author email corresponding author email

Breast Cancer Research 2006, 8:406doi:10.1186/bcr1413

The electronic version of this article is the complete one and can be found online at: http://breast-cancer-research.com/content/8/3/406

Published:

3 May 2006

Correction

It has been brought to our attention that there was a typographical error in our recent article [1] published in March 2006.

In the Conclusions section the final sentence should read:

Questions such as the optimal duration of therapy and efficacy in stage I disease remain to be answered.

References

Powles T, Paterson A, McCloskey E, Schein P, Scheffler B, Tidy A, Ashley S, Smith I, Ottestad L, Kanis J: Reduction in bone relapse and improved survival with oral clodronate for adjuvant treatment of operable breast cancer [ISRCTN83688026].
Breast Cancer Research 2006, 8:R13. PubMed Abstract | BioMed Central Full Text | PubMed Central Full Text

Correction: Reduction in bone relapse and improved survival with oral clodronate for adjuvant treatment of operable breast cancer [ISRCTN83688026]

Correction

References

Have something to say? Post a comment on this article!